title: Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.
authors.affiliation: Division of Pediatric Cardiology, Gazi University Medical School, Ankara, Turkey. arda@gazi.edu.tr
authors.forename: Arda
authors.initials: A
authors.lastname: Saygili
authors.forename: Berna
authors.initials: B
authors.lastname: Canter
authors.forename: Erkan
authors.initials: E
authors.lastname: Iriz
authors.forename: Serdar
authors.initials: S
authors.lastname: Kula
authors.forename: Fatma Sedef
authors.initials: FS
authors.lastname: Tunaoğlu
authors.forename: Rana
authors.initials: R
authors.lastname: Olguntürk
authors.forename: Mehmet Emin
authors.initials: ME
authors.lastname: Ozdoğan
mesh_terms: D000280:Administration, Inhalation; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006332:Cardiomegaly / Q000150:complications / Q000601:surgery; D002648:Child; D004334:Drug Administration Schedule; D004562:Electrocardiography / Q000379:methods; D006345:Heart Septal Defects, Ventricular / Q000150:complications / Q000601:surgery; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007442:Intubation, Intratracheal / Q000379:methods; D008297:Male; D009569:Nitric Oxide / Q000627:therapeutic use*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011182:Postoperative Care / Q000379:methods; D011687:Purines; D012720:Severity of Illness Index; D000068677:Sildenafil Citrate; D013450:Sulfones; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D001993:Bronchodilator Agents; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D009569:Nitric Oxide; D000068677:Sildenafil Citrate